Novo Nordisk A/S ADR buy melinda
Start price
06.07.17
/
50%
€37.95
Target price
29.08.17
€45.10
Performance (%)
11.71%
End price
29.08.17
€41.96
Summary
This prediction ended on 29.08.17 with a price of €41.96. The prediction had a final performance of 11.71%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S ADR | -0.398% | -0.398% | -16.944% | 91.131% |
iShares Core DAX® | -0.552% | 3.405% | 17.621% | 18.214% |
iShares Nasdaq 100 | -1.415% | 4.613% | 28.506% | 54.410% |
iShares Nikkei 225® | -0.877% | -1.396% | 9.284% | 4.292% |
iShares S&P 500 | -0.415% | 3.338% | 25.914% | 47.401% |
Comments by melinda for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Insulin-Pen
Diabetes
(Vom Mitglied beendet)
Stopped prediction by melinda for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€158.50
14.05.23
14.05.23
€165.00
14.05.24
14.05.24
-22.71%
15.05.24
15.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€43.06
01.09.17
01.09.17
€49.61
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.74
01.09.17
01.09.17
€55.00
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.07
06.07.17
06.07.17
€50.00
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€32.79
17.01.17
17.01.17
€33.37
24.04.17
24.04.17
2.29%
24.04.17
24.04.17